Shield Therapeutics PLC Stock
Your prediction
Shield Therapeutics PLC Stock
Shield Therapeutics PLC dominated the market today, gaining €0.021 (16.670%).
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 16.670% | 30.088% | 16.667% | 390.000% | 40.000% | 108.511% | -75.500% |
| Pets At Home Group Ls 1 | -0.520% | 0.871% | -2.196% | -7.508% | 0.871% | -40.000% | -49.211% |
| Card Factory plc | 0.820% | 0.543% | -5.612% | -29.791% | -2.632% | -27.165% | 77.033% |
| Rent-a-Center | - | 1.765% | 15.333% | -39.085% | 15.333% | -24.783% | -55.641% |
News
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty
Guardant Health (GH) Q2 Revenue Up 31%
Guardant Health (NASDAQ:GH), a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025. The